PRIMO CABG2

Related by string. * primo . Primos . Primo : iGO primo . Carlito Primo . Langstaff Primo Verdone . Primo Banquet Hall . Primo NBL . Primo Brezec . Primo Carnera . Primo Smallgoods . PRIMO . Primo Verdone . Primo Water . Primos Secane . Primo Levi . Los Primos . Primo Colon . Primo Pizza . Primo Nebiolo . il primo . Primos PA # . Il Primo . Primo Banquet Catering . Primos Hunting Calls . Primo Alui Joelianto / : * *

Related by context. Frequent words. (Click for all words.) 66 phase IIb clinical 64 Phase Ib clinical 64 elotuzumab 63 phase IIa 63 placebo controlled clinical 63 pharmacodynamic effects 62 SPIRIT III 62 subgroup analyzes 62 pexelizumab 62 Phase 2b study 62 axitinib 61 ILLUMINATE 61 deforolimus 61 phase IIb 61 secondary efficacy endpoints 61 omecamtiv mecarbil 61 phase 2a 60 placebo controlled Phase 60 ocrelizumab 60 Phase 1b trial 60 adecatumumab 60 cangrelor 60 romidepsin 60 Phase 2a trial 60 confirmatory Phase III 59 alvimopan 59 GSK# [001] 59 registrational 59 Panzem R 59 figitumumab 59 tolerated dose MTD 59 SPIRIT IV 59 Phase 2a clinical 59 ADHF 59 Azedra 59 Phase 1b 59 Asentar 59 dose escalation trial 59 Pivotal Phase 59 PROPEL trial 59 neurogenic orthostatic hypotension 58 randomized Phase III 58 PROMACTA 58 cerebrovascular events 58 ataluren 58 tesmilifene 58 dirucotide 58 placebo controlled clinical trials 58 pertuzumab 58 Genasense R oblimersen 58 Pivotal Trial 58 Phase IIa trial 58 IIa trial 58 senicapoc 58 Pivotal Phase III 58 muraglitazar 58 rNAPc2 58 dose titration 58 composite endpoint 58 achieved statistical significance 58 tolvaptan 58 R sorafenib tablets 58 TAXUS Stent 58 Cloretazine R VNP#M 58 Phenoptin 58 Phase 1b clinical 58 Phase Ib 57 CCX# 57 relapsed refractory multiple myeloma 57 unblinding 57 diabetic neuropathic pain 57 TELCYTA 57 registrational trial 57 Stedivaze 57 Board DSMB 57 TAXUS stent 57 prospective multicenter 57 nab paclitaxel 57 optimal dosing 57 nesiritide 57 darusentan 57 aclidinium 57 SABCS 57 double blinded placebo 57 Phase IIb clinical 57 Phase IIa clinical 57 eltrombopag 57 Phase 2b trial 56 noninferiority 56 teduglutide 56 HGS ETR1 56 cardiovascular morbidity 56 coronary revascularization 56 prespecified 56 cardiovascular hospitalization 56 glufosfamide 56 NSABP 56 ponatinib 56 myocardial ischemia 56 ischemic cardiomyopathy 56 thromboembolic

Back to home page